Atlas Trials

The Protection Effect of Speeda® Rabies Vaccine for Human Use

Clinical trial NCT01827917 · COMPLETED

Trial details

NCT number
NCT01827917
Sponsor
Beijing Center for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rabies Vaccine Allergy
Start date
2013-02-01
Primary completion
2013-12-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.